Natroceutics® Berberine Complex — Increased Bioavailability & Dual Release AMPK Activator
Berberine is recognised as an AMPK (adenosine monophosphate protein kinase) activator, a crucial enzyme in metabolic regulation. This complex features an advanced liposomal delivery system designed to overcome traditional bioavailability challenges, ensuring effective absorption. Natroceutics® Berberine Complex provides berberine alongside liposomal chromium to support healthy glucose and lipid metabolism. Its dual-release mechanism optimises the sustained activation of AMPK, contributing to balanced blood sugar levels and overall metabolic health.
Recommended Usage
Adults and children over 12 years: Take 1 capsule once or twice per day at the start of the largest meals of the day or as directed by your healthcare professional.
Composition
| Serving size: 1 capsule | Amount per serving |
| Berberine HCl (of which 50 mg is liposomal berberine HCl) | 550mg |
| Liposomal chromium equivalent to elemental chromium (with 23 mg phospholipids from the liposomal bilayer) | 25mcg |
Other Ingredients
Brown rice flour, magnesium stearate and silicon dioxide in a clear vegetable capsule
Does Not Contain
GMO and sugar
Suitable for vegans and vegetarians
Storage
Store in a cool dry place (<25°C), away from sunlight. Keep out of reach of children.
Product Form
Capsule
Warnings/Contraindication
If pregnant, nursing or taking medication, consult your healthcare practitioner before use.
Do not use this product if you have an allergy or sensitivity to any of the ingredients.
Keep out of reach of children.
Natroceutics® Berberine Complex is not recommended for children younger than 12 years due to insufficient available evidence.
Patients with hypersensitivity to berberine, tree turmeric, goldenseal, goldthread, oregan grape, European barberry, phellodendron, chromium, leather, or any of the other components of the formulation.
The berberine and chromium in Natroceutics® Berberine Complex may increase the risk of low blood glucose levels in patients treated with antidiabetic medicines, including insulin, and careful monitoring of blood glucose levels is required, especially at the onset of treatment. Dosage adjustments of antidiabetic medicines may be required under supervision of a medical doctor.
The concurrent use of Natroceutics® Berberine Complex and ciclosporin is contraindicated since berberine may reduce metabolism and increase serum levels of ciclosporin.
Use of Natroceutics® Berberine Complex is contraindicated during pregnancy. Its constituent, berberine, is thought to cross the placenta and may have detrimental effects on the foetus. Kernicterus has been reported in new-born infants who were exposed to berberine. Berberine may also stimulate uterine contractions.
Berberine in Natroceutics® berberine complex may pass into breast milk. Use during lactation is contraindicated.
For further information on drug-interactions, side-effects and precautions, please refer to patient information leaflet inside the box.



